|
USA-TN-HERMITAGE Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- RINVOQ® (upadacitinib) for Ulcerative Colitis (UC)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- Taking RINVOQ® (upadacitinib) for Ulcerative Colitis
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- What Is RINVOQ® (upadacitinib) for Ulcerative Colitis?
RINVOQ is a JAK inhibitor taken orally as a once-daily pill to treat moderate to severe ulcerative colitis (UC) when 1 or more medicines called tumor necrosis factor (TNF) blockers such as HUMIRA ® or REMICADE ® have been used and did not work well RINVOQ works with your body to fight the inflammation that can lead to UC symptoms Because JAK inhibitors, including RINVOQ, affect the immune
- RINVOQ® (upadacitinib) Results for Ulcerative Colitis (UC)
Adult patient with moderate to severe UC received RINVOQ 45 mg (induction) and 30 mg (maintenance), once daily RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated
- UC Treatment Options | RINVOQ® (upadacitinib)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- RINVOQ® (upadacitinib) for RA, PsA, AD, AS, nr-axSpA, UC, CD, pJIA JPsA
RINVOQ RINVOQ LQ is a prescription medicine used to treat: Children 2 years of age and older with active polyarticular juvenile idiopathic arthritis (pJIA) when 1 or more medicines called TNF blockers have been used, Adults with moderate to severe ulcerative colitis
- What Is Ulcerative Colitis (UC)? | RINVOQ® (upadacitinib)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- Setting Goals for UC Treatment | RINVOQ® (upadacitinib)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- Choosing a UC Treatment | RINVOQ® (upadacitinib)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
- How RINVOQ® (upadacitinib) Works for Ulcerative Colitis (UC)
RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated It is not known if RINVOQ is safe and effective in children with ulcerative colitis
|
|